The comparison of the effect of magnesium oxide and sodium valproate in migraine prophilaxis:
Not Applicable
- Conditions
- Migrain headache.Migraine
- Registration Number
- IRCT2015011716666N2
- Lead Sponsor
- Mazandaran University of Medical Sceinces
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
migraine headache on based criteria IHS; age between 15-65 years old; migraine headache from 6 month ago; headache frequency: more than twice a month with moderate or sever intensity; not used valproate Na and MG within the past 30 days.
Exclusion criteria: pregnancy; breastfeeding; renal and hepatic failure; non migraine headache; smoking and opium and substance abuse.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Headache intensity. Timepoint: 2 months after used drug. Method of measurement: Questionnaire MIDAS and VAS 1-10.;Headache frequency. Timepoint: 2 months after used drug. Method of measurement: Questionnaire MIDAS.;Headache duration. Timepoint: 2 months after used drug. Method of measurement: Questionnaire MIDAS.
- Secondary Outcome Measures
Name Time Method Headache symptom. Timepoint: 2 month after use drug. Method of measurement: Questionnair.